| Application no. and date | 19203616.8 (espacenet) (Federated) (European Patent Register), 20120907 | | Patent/reg. no. and date | DK/EP 3616695, 20241023 | | Publication date | 20200304 | | Priority no. and date | US 201161532914 P, 20110909, US 201261657386 P, 20120608 | | EP pub. no. and date |
EP 3616695 20200304 | | Effective date | | | Applicant/owner | Merck Sharp & Dohme LLC, 126 East Lincoln Avenue
Rahway, New Jersey 07065, US | | Applicant ref. no. | PU282608DKQ | | Inventor | Chandorkar, Gurudatt, A., 267 Bishops Forest Drive
Waltham, MA Massachusetts 02452, US,
Parsons, Tara, 32 Shingle Mill Lane
Hanover, MA Massachusetts 02339, US,
HUNTINGTON, Jennifer, A., 55 Grand Street
Reading, MA Massachusetts 01867, US,
UMEH, Obiamiwe, C., 57 Stoneymeade Way
Acton, MA Massachusetts 01720, US | | Representative | Marks & Clerk LLP, 44, rue de la Vallée
L-2661 Luxembourg, LU | | Opponent | | | IPC Class | A61K 31/397 (2006.01) , A61K 31/431 (2006.01) , A61K 31/546 (2006.01) , A61K 9/00 (2006.01) , A61P 31/04 (2006.01) | | Title | CEFTOLOZAN/TAZOBACTAM TIL BEHANDLING AF INTRAPULMONALE INFEKTIONER | | Int. application no. | | | Int. publication no. | | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
